Subretinal surgery for juxtafoveal choroidal neovascularization

Retina

Volumn 23, Issue 4, 2003, Pages 463-468

  Joseph, Daniel P ^a,c   Uemura, Akinori ^b   Thomas, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MALE; MYOPIA; OCULAR HISTOPLASMOSIS; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RECURRENT DISEASE; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; SURGICAL APPROACH; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETINA; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 0041836109     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200308000-00003     Document Type: Article

References (15)

1. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol 1987;105:1499-1507.
2. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1990;108:816-824.
3. Macular Photocoagulation Study Group. Krypton laser photocoagulation for idiopathic neovascular lesions: results of a randomized clinical trial. Arch Ophthalmol 1990;108:832-837.
4. Macular Photocoagulation Study Group. Laser photocoagulation of juxtafoveal choroidal neovascularization. Arch Ophthalmol 1994;112:500-509.
5. Macular Photocoagulation Study Group. The influence of treatment extent on the visual acuity of eyes treated with krypton laser for juxtafoveal choroidal neovascularization. Arch Ophthalmol 1995;113:190-194.
6. Melberg NS, Thomas MA, Burgess DB. The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome. Retina 1996;16:190-195.
7. Macular Photocoagulation Study Group. Argon laser photocoagulation for histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol 1983;101:1347-1357.
8. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes, Ophthalmology 1994;101:1384-1396.
9. Macular Photocoagulation Study Group. Argon laser photocoagulation of senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1982;100:912-918.
10. Macular Photocoagulation Study Group. Argon laser photocoagulation for idiopathic neovascularization: results of a randomized clinical trial. Arch Ophthalmol 1983;101:1358-1361.
11. Gass JMD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1194;118:285-298.
12. Joseph DP, Thomas MA. Present indications for removal of choroidal neovascular membranes. Curr Opin Ophthalmol 1998;9:23-30.
13. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol 1989;107:344-352.
14. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990;108:825-831.
15. Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. Ophthalmology 1997;104:22-26.